JCOG

The Japan Clinical Oncology Group (JCOG) is the largest Japanese cooperative group funded primarily by the National Cancer Center Research and Development Fund.

HBPOG:Hepatobiliary and Pancreatic Oncology Group / Publications

更新日:2013年11月8日

a. 論文

1. 委員会承認の治療研究

H Ishii, J Furuse, N Boku, et al.: JCOG Gastrointestinal Oncology Study Group. Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506. Jpn J Clin Oncol. 40(6): 573-579, 2010.
A Takashima, C Morizane, H Ishii, et al.: Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805). J. Jpn J Clin Oncol. 40(12): 1189-1191, 2010.
C Morizane, T Okusaka, J Mizusawa, et al.: Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805). Cancer Sci. 2013 Jun 14. doi: 10.1111/cas.12218. [Epub ahead of print]

2. グループ代表者管理の治療研究

K Nakachi, J Furuse, T Kinoshita, et al.: A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Cancer Chemother Pharmacol. 66(3): 527-534, 2010.
H Ueno, T Okusaka, J Furuse, et al.: Multicenter phase II study of gemcitabine and S-1 combination therapy (GS therapy) in patients with metastatic pancreatic cancer. Jpn J Clin Oncol. 41(8):953-958. 2011.
M Ikeda, T Ioka, Y Ito, et al.: A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 85(1): 163-169, 2013.
M Ikeda, T Okusaka, J Furuse, et al.: A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemother Pharmacol 72(2): 463-470, 2013.
E Suzuki, M Ikeda, T Okusaka, et al.: A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer. Cancer Chemother Pharmacol 71(5): 1141-1146, 2013.

3. 附随研究等

なし  

4. 総説・解説

古瀬純司:膵癌の内科治療.日本医事新報4457. 46-50, 2009.
古瀬純司、鈴木英一郎、長島文夫:胆道癌治療における癌化学療法の新たな展開. 胆道癌化学療法:GemcitabineS-1導入後の新たな展開. 胆と膵. 30:1421-1426, 2009.
古瀬純司:医学と医療の最前線「膵癌化学療法の最前線」. 日本内科学会雑誌. 99:842-848, 2010.
M Konishi: Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction. J Hepatobiliary Pancreat Sci 19(4): 301-305, 2012
J Furuse, A Kasuga, A Takasu, et al.: Role of chemotherapy in treatments for biliary tract cancer. J Hepatobiliary Pancreat Sci 19(4): 337-341, 2012.
J Furuse, H Ishii, T Okusaka: The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction. Jpn J Clin Oncol 43(1): 2-7, 2013.

b. 主な学会発表

1. 委員会承認の治療研究

石井浩、他:Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506. 第8回日本臨床腫瘍学科器学術集会. 2010年3月.
C Morizane, et al.: Randomized phase IIlus S-1 combination therapy versus S-1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805) (abstract 255). Gastrointestinal Cancers Symposium. Jan 2012.
M Ueno, et al.: Randomized phase II trial of gemcitabine plus S?1 com trial of gemcitabine pbination therapy versus S?1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805). 48th ASCO Annual Meeting. J Clin Oncol 30 (suppl; abstr 4031). Jun 2012.

2. グループ代表者管理の治療研究

M Konishi,K Nakachi: Feasibility Study of S-1 in Resected Biliary Tract Cancer. Asia Pacific HPBA Congress 2011. (abstract P205), Sep 2011.
小西大、仲地耕平: 胆道癌根治切除例に対するS-1による補助化学療法の安全性確認試験. 第47回日本胆道学会学術集会. 2011年9月.
T Yamaguchi, et al.: Multicenter retrospective analysis of systemic chemotherapy in poorly differentiated neuroendocrine carcinoma of the digestive system (abstract 274). Gastrointestinal Cancers Symposium. Jan 2012.
N Machida, et al.: Multicenter retrospective analysis of systemic chemotherapy for advanced poorly differentiated neuroendocrine carcinoma of the digestive system. 48th ASCO Annual Meeting. J Clin Oncol 30 (suppl; abstr 4046). Jun 2012.
仲地耕平、他:進行肝内胆管癌に対するシスプラチン肝動注化学療法の多施設共同第II相試験. 第10回日本臨床腫瘍学会学術集会. 2012年7月.
春日章良、他: 消化器原発低分化型神経内分泌癌に対する全身化学療法の多施設共同観察研究. 2012年7月.
小西 大、池田公史、仲地耕平: 胆道癌根治切除例に対するS-1による術後補助化学療法の多施設共同臨床試験. 第48回日本胆道学会学術集会. 2102年9月.

3. 附随研究等

なし  

4. 総説・解説

なし